H Mori Selected Research

H Mori Research Topics

Disease

28	Neoplasms (Cancer) 01/2020 - 01/2000
25	Carcinogenesis 01/2004 - 01/2000
14	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2000
13	Body Weight (Weight, Body) 09/2001 - 02/2000
8	Ischemia 05/2008 - 02/2000
8	Aberrant Crypt Foci 08/2002 - 01/2000
7	Infarction (Infarctions) 08/2003 - 08/2000
6	Infections 02/2014 - 02/2000
5	Carcinoma (Carcinomatosis) 01/2008 - 07/2000
4	Colorectal Neoplasms (Colorectal Cancer) 02/2009 - 01/2000
4	Reperfusion Injury 05/2008 - 01/2001
4	Amyloid Plaque 11/2002 - 09/2000
4	Pain (Aches) 08/2001 - 01/2000
3	Fibrosis (Cirrhosis) 01/2020 - 12/2000
3	Type 2 Diabetes Mellitus (MODY) 05/2013 - 04/2001
3	Adenoma (Adenomas) 01/2013 - 06/2001
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2012 - 10/2000
3	Hypoxia (Hypoxemia) 05/2008 - 06/2000
3	Wounds and Injuries (Trauma) 05/2008 - 11/2000
3	Endometrial Neoplasms (Endometrial Cancer) 03/2005 - 01/2000
3	Heart Failure 12/2001 - 08/2001
3	Parkinsonian Disorders (Parkinsonism) 10/2001 - 02/2001
3	Hyperalgesia 08/2001 - 01/2000
3	Colonic Neoplasms (Colon Cancer) 06/2001 - 11/2000
3	Dementia (Dementias) 04/2001 - 01/2000
3	Necrosis 10/2000 - 01/2000
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 01/2003
2	Insulin Resistance 07/2018 - 02/2000
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2018 - 01/2001
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 01/2008
2	Lymphoma (Lymphomas) 02/2015 - 10/2001
2	Ulcer 01/2014 - 07/2012
2	Pneumonia (Pneumonitis) 08/2012 - 12/2010
2	Bronchiectasis 03/2011 - 03/2009
2	Encephalitis (Encephalitis, Rasmussen) 12/2010 - 10/2003
2	Coronary Occlusion 05/2008 - 10/2001
2	Myocardial Ischemia (Ischemic Heart Diseases) 05/2008 - 10/2000
2	Hepatocellular Carcinoma (Hepatoma) 06/2005 - 11/2000
2	Shock 01/2005 - 11/2004
2	Dyspnea (Shortness of Breath) 07/2004 - 07/2000
2	Acidosis 09/2002 - 09/2001
2	Adenocarcinoma 12/2001 - 07/2001
2	Corticobasal Degeneration 11/2001 - 03/2000
2	Parkinson Disease (Parkinson's Disease) 10/2001 - 05/2001

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2004 - 01/2000
7	beta CateninIBA 08/2002 - 07/2000
6	AzoxymethaneIBA 09/2001 - 01/2000
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2005 - 01/2000
5	Amyloid beta-PeptidesIBA 11/2002 - 01/2000
5	CarcinogensIBA 08/2002 - 07/2000
5	Estrogens (Estrogen)FDA Link 09/2001 - 01/2000
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2000
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2000
4	Peroxidase (Myeloperoxidase)IBA 04/2017 - 09/2000
4	Messenger RNA (mRNA)IBA 02/2009 - 03/2000
4	Biological ProductsIBA 09/2003 - 08/2000
4	cytidylyl-(3'-5')-cytidine (CpC)IBA 11/2001 - 03/2000
4	Presenilin-1IBA 07/2001 - 01/2000
3	Hormones (Hormone)IBA 01/2020 - 01/2001
3	Pharmaceutical PreparationsIBA 07/2018 - 05/2001
3	DNA (Deoxyribonucleic Acid)IBA 06/2009 - 02/2000
3	AntibodiesIBA 12/2001 - 10/2000
3	CurcuminIBA 09/2001 - 09/2000
3	Capsaicin (Zostrix)FDA Link 08/2001 - 01/2000
3	ferric oxide (iron oxide)IBA 12/2000 - 07/2000
3	nitrosobenzylmethylamineIBA 09/2000 - 02/2000
2	SaltsIBA 07/2018 - 09/2011
2	IsoflavonesIBA 07/2018 - 07/2001
2	PotassiumIBA 07/2018 - 06/2000
2	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 05/2001
2	Hyaluronic Acid (Hyaluronan)IBA 12/2016 - 05/2001
2	SteroidsIBA 07/2012 - 10/2001
2	CytokinesIBA 06/2009 - 07/2001
2	Dialysis SolutionsIBA 05/2008 - 10/2001
2	Contrast MediaIBA 05/2007 - 07/2000
2	Glutamate Receptors (Glutamate Receptor)IBA 10/2003 - 03/2001
2	EpitopesIBA 10/2003 - 08/2001
2	N-Methylaspartate (NMDA)IBA 10/2003 - 03/2001
2	SolutionsIBA 09/2003 - 04/2001
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2003 - 03/2000
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2003 - 06/2001
2	Adenosine Triphosphate (ATP)IBA 09/2002 - 01/2001
2	GhrelinIBA 12/2001 - 09/2001
2	Methylnitronitrosoguanidine (MNNG)IBA 09/2001 - 09/2001
2	juzentaihotoIBA 09/2001 - 04/2001
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2001 - 03/2000
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 09/2001 - 04/2001
2	1'-acetoxychavicol acetateIBA 09/2001 - 02/2000

Therapy/Procedure

6	Therapeutics 01/2019 - 07/2000
3	Surgical Instruments (Clip) 01/2014 - 07/2012
3	Traction 01/2013 - 03/2009
3	Synchrotrons 05/2007 - 10/2000
3	Injections 07/2000 - 02/2000
2	Adjuvant Chemotherapy 01/2017 - 01/2008
2	Transplantation 02/2015 - 04/2005
2	Aftercare (After-Treatment) 03/2009 - 11/2000
2	Drug Therapy (Chemotherapy) 01/2008 - 02/2001
2	Intravenous Administration 11/2004 - 01/2001
2	Chemoprevention 08/2002 - 09/2001
2	Subcutaneous Injections 09/2001 - 01/2000